DHG Pharmaceutical JSC (HOSE:DHG)

Vietnam flag Vietnam · Delayed Price · Currency is VND
96,500
-1,400 (-1.43%)
At close: Apr 22, 2025
-13.69%
Market Cap 12.68T
Revenue (ttm) 4.82T
Net Income (ttm) 796.24B
Shares Out 130.75M
EPS (ttm) 6,089.52
PE Ratio 15.93
Forward PE 14.59
Dividend 7,500.00 (7.77%)
Ex-Dividend Date Dec 24, 2024
Volume 25,000
Average Volume 28,625
Open 97,000
Previous Close 97,900
Day's Range 95,000 - 97,900
52-Week Range 87,000 - 125,900
Beta 0.46
RSI 50.45
Earnings Date Apr 18, 2025

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in dietary supplements and pharmaceuticals cosmetics. The company exports its products to approximately 20 countries. The company was founded... [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 2,806
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol DHG
Full Company Profile

Financial Performance

In 2024, DHG Pharmaceutical JSC's revenue was 4.88 trillion, a decrease of -2.60% compared to the previous year's 5.02 trillion. Earnings were 753.55 billion, a decrease of -25.91%.

Financial Statements

News

There is no news available yet.